2022
DOI: 10.1002/jcla.24779
|View full text |Cite
|
Sign up to set email alerts
|

Circulating microbiota and metabolites: Insights into cardiovascular diseases

Abstract: Background:In almost every country, cardiovascular diseases are the major cause of death, which are responsible for 17.7 million deaths worldwide, or 54% of all deaths.However, the latest evidence has shown that non-communicable diseases such as obesity, diabetes, and cardiovascular events are significantly influenced by the blood microbiota and circulating metabolites. Methods:We searched online databases for the most recent related papers through the comprehensive international databases of the Institute of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 109 publications
(251 reference statements)
0
3
0
Order By: Relevance
“…Conversely, we found no association between BB-DNA with other pre‐existing comorbidities such as hypertension, stroke, COPD, or ischemic heart disease. Very few studies in the literature measure BB-DNA levels in age-related diseases, and an increase in circulating bacterial DNA has been observed in cardiovascular (CVD) patients compared with healthy individuals and associated with cardiovascular events in peritoneal dialysis patients [ 41 , 42 ]. However, the lack of association between BB-DNA and CVD may depend on the small sample size and differences in the clinical characteristics of the patients studied.…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, we found no association between BB-DNA with other pre‐existing comorbidities such as hypertension, stroke, COPD, or ischemic heart disease. Very few studies in the literature measure BB-DNA levels in age-related diseases, and an increase in circulating bacterial DNA has been observed in cardiovascular (CVD) patients compared with healthy individuals and associated with cardiovascular events in peritoneal dialysis patients [ 41 , 42 ]. However, the lack of association between BB-DNA and CVD may depend on the small sample size and differences in the clinical characteristics of the patients studied.…”
Section: Discussionmentioning
confidence: 99%
“…It has been hypothesized that intestinal microbes confer many metabolic capabilities needed for the preservation of the host’s immune homeostasis and that alterations of the gut microbiome composition (dysbiosis) could lead to immune alterations contributing to the development of a number of systemic disorders [ 23 , 24 ] Notably, numerous studies have shown its association with a number of inflammatory and autoimmune conditions such as inflammatory bowel disease and lupus nephritis, while a number of persuasive interventional studies have further demonstrated that microbiome modulating strategies, such as fecal microbiota transplantation (FMT), can induce remission of some of these conditions and modulate treatment response [ 25 , 26 , 27 , 28 , 29 ].…”
Section: Gut Microbiomementioning
confidence: 99%
“…It is now known that the brain regulates intestinal functions in communication with the hypothalamic-pituitary-adrenal axis, as well as the autonomic nervous system (ANS) [4,5]. In addition, the intestine modulates certain functions in the central nervous system (CNS) involving various metabolites produced by the microbiota, as certain gut hormones and neuroactive compounds that propagate through the enteric nervous system 2 of 38 (ENS), the circulatory system, the vagus nerve, or the immune system, until reaching the brain [6,7]. This chain of communication forms the so-called microbiota-gut-brain axis, where it is estimated that 10 13 -10 14 live microorganisms exist.…”
Section: Introduction 1microbiota and Neurodegenerationmentioning
confidence: 99%